Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon D Laman

Showing results (11-20 of 175) with videos related to

Pageof 18
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|January 8, 2017
Reproducibility Issues: Avoiding Pitfalls in Animal Inflammation ModelsJon D Laman, Susanne M Kooistra, Björn E Clausen
Iscience|February 14, 2023
COVID-19 morbidity in lower versus higher income populations underscores the need to restore lost biodiversity of eukaryotic symbiontsWilliam Parker, Esha Patel, Kateřina Jirků-Pomajbíková, et al.
Clinical Pharmacology and Therapeutics|July 28, 2017
Reverse Translation for Assessment of Confidence in Animal Models of Multiple Sclerosis for Drug DiscoveryBert A 't Hart, Jon D Laman, Yolanda S Kap
Trends in Molecular Medicine|May 20, 2009
Multiple sclerosis - a response-to-damage modelBert A 't Hart, Rogier Q Hintzen, Jon D Laman
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 15, 2009
Experimental autoimmune encephalomyelitis in the common marmoset, a bridge between rodent EAE and multiple sclerosis for immunotherapy developmentYolanda S Kap, Jon D Laman, Bert A 't Hart
Expert Opinion on Drug Discovery|February 22, 2018
Merits and complexities of modeling multiple sclerosis in non-human primates: implications for drug discoveryBert A 't Hart, Jon D Laman, Yolanda S Kap
Neuro-Degenerative Diseases|December 14, 2007
Preclinical assessment of therapeutic antibodies against human CD40 and human interleukin-12/23p40 in a nonhuman primate model of multiple sclerosisBert A 't Hart, Rogier Q Hintzen, Jon D Laman
Journal of Molecular Medicine (Berlin, Germany)|September 20, 2018
Targeting senescence to delay progression of multiple sclerosisWendy Oost, Nynke Talma, Jan F Meilof, et al.
Evolution, Medicine, and Public Health|June 25, 2021
Authors' response to Graham Rook's commentaryWilliam Parker, Joshua T Sarafian, Sherryl A Broverman, et al.
Trends in Immunology|March 8, 2022
Guillain-Barré syndrome: expanding the concept of molecular mimicryJon D Laman, Ruth Huizinga, Geert-Jan Boons, et al.
Pageof 18

Showing results (11-20 of 175) with videos related to

Sort By:
Pageof 18
Methods in Molecular Biology (Clifton, N.J.)|January 8, 2017
Reproducibility Issues: Avoiding Pitfalls in Animal Inflammation ModelsJon D Laman, Susanne M Kooistra, Björn E Clausen
Iscience|February 14, 2023
COVID-19 morbidity in lower versus higher income populations underscores the need to restore lost biodiversity of eukaryotic symbiontsWilliam Parker, Esha Patel, Kateřina Jirků-Pomajbíková, et al.
Clinical Pharmacology and Therapeutics|July 28, 2017
Reverse Translation for Assessment of Confidence in Animal Models of Multiple Sclerosis for Drug DiscoveryBert A 't Hart, Jon D Laman, Yolanda S Kap
Trends in Molecular Medicine|May 20, 2009
Multiple sclerosis - a response-to-damage modelBert A 't Hart, Rogier Q Hintzen, Jon D Laman
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 15, 2009
Experimental autoimmune encephalomyelitis in the common marmoset, a bridge between rodent EAE and multiple sclerosis for immunotherapy developmentYolanda S Kap, Jon D Laman, Bert A 't Hart
Expert Opinion on Drug Discovery|February 22, 2018
Merits and complexities of modeling multiple sclerosis in non-human primates: implications for drug discoveryBert A 't Hart, Jon D Laman, Yolanda S Kap
Neuro-Degenerative Diseases|December 14, 2007
Preclinical assessment of therapeutic antibodies against human CD40 and human interleukin-12/23p40 in a nonhuman primate model of multiple sclerosisBert A 't Hart, Rogier Q Hintzen, Jon D Laman
Journal of Molecular Medicine (Berlin, Germany)|September 20, 2018
Targeting senescence to delay progression of multiple sclerosisWendy Oost, Nynke Talma, Jan F Meilof, et al.
Evolution, Medicine, and Public Health|June 25, 2021
Authors' response to Graham Rook's commentaryWilliam Parker, Joshua T Sarafian, Sherryl A Broverman, et al.
Trends in Immunology|March 8, 2022
Guillain-Barré syndrome: expanding the concept of molecular mimicryJon D Laman, Ruth Huizinga, Geert-Jan Boons, et al.
Pageof 18